{"title":"内皮-间充质转化(EndoMT)","authors":"","doi":"10.33140/icvpr.01.01.02","DOIUrl":null,"url":null,"abstract":"EndoMT is a complex biological process in which endothelial cells lose their specific markers and acquire a mesenchymal phenotype and express mesenchymal cell products. Endo-MT has been reported to occur in fibrosis-related disease. Current study strongly supports the reality of an EndoMT phenomenon in human disease and expands its biological role beyond fibrosis. Recent studies have demonstrated that the occurrence of EndoMT is clearly associated with inflammation and EndoMT is one of the primary drivers of vascular inflammation.","PeriodicalId":185967,"journal":{"name":"Insights of Cardiovascular Pharmacology Research","volume":"20 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Endothelial-Mesenchymal Transition (EndoMT)\",\"authors\":\"\",\"doi\":\"10.33140/icvpr.01.01.02\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"EndoMT is a complex biological process in which endothelial cells lose their specific markers and acquire a mesenchymal phenotype and express mesenchymal cell products. Endo-MT has been reported to occur in fibrosis-related disease. Current study strongly supports the reality of an EndoMT phenomenon in human disease and expands its biological role beyond fibrosis. Recent studies have demonstrated that the occurrence of EndoMT is clearly associated with inflammation and EndoMT is one of the primary drivers of vascular inflammation.\",\"PeriodicalId\":185967,\"journal\":{\"name\":\"Insights of Cardiovascular Pharmacology Research\",\"volume\":\"20 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-11-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Insights of Cardiovascular Pharmacology Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33140/icvpr.01.01.02\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Insights of Cardiovascular Pharmacology Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33140/icvpr.01.01.02","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
EndoMT is a complex biological process in which endothelial cells lose their specific markers and acquire a mesenchymal phenotype and express mesenchymal cell products. Endo-MT has been reported to occur in fibrosis-related disease. Current study strongly supports the reality of an EndoMT phenomenon in human disease and expands its biological role beyond fibrosis. Recent studies have demonstrated that the occurrence of EndoMT is clearly associated with inflammation and EndoMT is one of the primary drivers of vascular inflammation.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
